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Andrew S Brack1,2,3Abstract
Two recent studies have reinvigorated the conversation regarding the role of Pax7 in adult satellite. Studies by
Gunther et al (Cell Stem Cell 13:590 ? 601, 2013) and Von Maltzhen et al (Proc Natl Acad Sci U S A 110:16474 ? 16479)
show that Pax7 is critical for adult satellite cell function and their contribution to muscle repair. Previously, Lepper
et al (Nature 460:627? 631, 2009) demonstrated that Pax7 was dispensable for adult muscle repair. In this
commentary I have summarized the results from these studies, focusing on the differences in experimental
paradigms that led the authors to different conclusions. I also take this opportunity to discuss the potential
limitations and hurdles of Cre-lox technology that are responsible for the discrepant results.
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Adult skeletal muscle has a remarkable regenerative
capacity due to a rare population of cells termed satellite
cells that are wedged between the basal lamina and
sarcolemma, interspersed along each adult muscle fiber
[1]. Since the original characterization of Pax7 as a specific
marker of adult satellite cells there has been a concerted
effort among skeletal muscle biologists to ascertain its role
in satellite cell function [2]. Germline mutants and in vitro
knockdown studies have all convincingly shown a key role
for Pax7 in survival and proliferative potential of satellite
cells and their committed progenitors, called myoblasts
[2-5]. Until recently, a definitive demonstration for the
functional role of Pax7 in adult satellite cells in vivo was
lacking. Over the past 5 years, three laboratories have
examined the requirement for Pax7 in adult satellite cells
using an inducible mouse strain that allowed Pax7 to be
normally expressed during development and subsequently
deleted in adult mice [6-8]. While the mouse genetics
used by the labs were identical, the regimens employed to
delete Pax7 were not, resulting in very different outcomes
and interpretations.Correspondence: brack.andrew@mgh.harvard.edu
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Since the first description of gene targeted mice in 1989,
which led to the Nobel Prize being given to Cappeci,
Evans, and Smithies in 2007, there has been an exponential
use of genetic mutant mouse models to study mammalian
gene function. Today, sophisticated genetic strategies that
allow biologists to delete a gene of interest from a cell
and its descendants in a temporally controlled manner
have now become almost commonplace. The tamoxifen
(TMX) inducible Cre lox system is used most frequently
in mouse models. A modifed Cre recombinase fused with
an estrogen receptor is expressed under the control of a
specific promoter, selected due to its tissue or cell type
restricted expression. Active Cre will recombine loxP sites,
engineered to flank a gene of interest, resulting in a null
allele. This approach has been used to indelibly mark and
track a cell and its descendants. In such cases, loxP sites
flank a stop sequence upstream of a fluorescent gene
reporter inserted into the accessible ROSA26 locus.
The muscle scientific community is fortunate to have
has four different inducible Pax7 Cre alleles at its disposal
[6,7,9,10]. All four lines are knockin alleles, three contain-
ing an internal ribsome entry site (IRES) to retain Pax7
translation [7,9,10], and one with increased Cre sensitivity
(CreERT2) [10].
To test the requirement for Pax7 in adult satellite cells,
that is, delete Pax7 from Pax7 expressing satellite cells,
the laboratories of Fan, Rudnicki, and Braun used a mouse
strain that harbored the same Pax7-loxP and TMX-
inducible Pax7Cre allele, developed by Lepper et al. TMXis an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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to injury, 5 days prior to injury, immediately prior to
injury and during repair, and prior to injury with a long
chase period, in the range of 1 to 8 months (see Figure 1).
The results clearly show that satellite cell function and
regeneration capacity is significantly impacted when TMX
is chased for long periods prior to injury or administered
during repair. In response to muscle injury, there was a
reduction in the number of Pax7-expressing cells, progres-
sive loss of muscle tissue, increased myofibroblasts, and
an accumulation of fatty infiltrate [7,8]. Importantly, tar-
geting Pax7 in satellite cells and their progeny in a cell
culture model reduced satellite cell proliferative capacity,
due to precocious differentiation. In stark contrast, regen-
eration was unaffected if a short chase (5 days) followed
TMX administration prior to muscle injury [6]. Despite
the normal regenerative output, assessment of recom-
bination based on β-galactosidase (β-gal) activity driven
off a ROSA26.LacZ reporter revealed a robust contribu-
tion from recombined Pax7+ satellite cells to regeneratingFigure 1 Strategies to target Pax7 cells using inducible Cre recombin
during muscle regeneration. Upper box: In response to injury, Pax7+ sate
rapidly dividing transit amplifying progenitor cells (TAC, blue) that different
levels (-) (red) before forming new muscle. Proliferating Pax7+ SCs return to
facultative cells (cyan) that express Pax7 transcript transiently (+/-) enter th
TMX strategies (blue box) employed to target Pax7+ cells, before (followed
at around 10 days in vivo, therefore recombination of Pax7+ cells is possibl
If TMX is administered shortly before or during injury, Cre has the potentia
facultative cells that transiently express Pax7 transcript as part of the regen
targeted. In all of these aforementioned scenarios, deletion of Pax7 gene if
the expense of identifying the cell state that requires the gene. Targeting w
made against the QSC. This is critical since Pax7 levels differ across the QSCmuscle fibers. In support of their in vivo findings, Lepper
et al. reported that freshly isolated β-gal + satellite cells
appeared to be capable of normal replication and differen-
tiation in cultured conditions.
Two compounding factors are likely responsible for
the different outcomes of Pax7 deletion on muscle repair:
(1) limitations in Cre lox technology, and (2) the insatiable
contribution of optimally functioning satellite cells to the
muscle repair process. Successful application of inducible
Cre lox technology relies on many individual elements
working optimally, including uniform Cre activation
in all cells within a target population, efficient gene
recombination, and loss of the gene product (protein).
In the presence of suboptimal gene targeting, resulting
cellular phenotypes can be misinterpreted as evidence for
redundant gene function.
The potency of Pax7 expressing satellite cells to prolifer-
ate and repair tissue is unquestionable. Therefore, a rare
non-recombined satellite cell with presumed normal func-
tion (? escaper ? cell) will propagate under the stimulus ofation and its implications for defining the cellular dynamics
llite cells exit from quiescence (QSC) (grey cells) to produce Pax7+
iate (myogenic progenitor cell, MPC), coupled to a decrease in Pax7
quiescence (grey cells) and reoccupy the niche. After injury,
e muscle and contribute to the repair process. Lower box: Different
by a chase: dashed line) and during injury. TMX half-life is estimated
e following the TMX administration regimen (green box and triangle).
l to recombine escaper Pax7+ QSCs as they proliferate (TAC). Other
eration process and SCs that return back to quiescence can also be
functionally important, will exacerbate the muscle phenotype, but at
ith TMX months prior to injury allows a definitive conclusion to be
compartment and change dynamically during lineage progression.
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et al. demonstrated extensive contribution of recombined
(β-gal+) Pax7 derived cells to regenerated muscle fibers.
However, strict conclusions on recombination efficiency
cannot be drawn in a multinucleated syncytium such as
skeletal muscle; it cannot be ruled out that ? escaper ? cells
contributed extensively to regenerated muscle fibers.
To analyze recombination at the level of Pax7, Lepper
et al. isolated whole muscle or small numbers of cells
from muscle tissue, with both methods showing Pax7
was not expressed after TMX administration. In con-
trast, Van Maltzhan et al. demonstrated that when a
population of TMX treated satellite cells is contaminated
with rare escaper cells, this small fraction of wild type
cells could proliferate and out-compete the majority of
recombined cells, achieving a repopulation of the cell pool
with wild type function. This warns against performing
analysis on low cell numbers and from whole tissue when
making interpretations about rare cell populations. More-
over, during the course of our experiments using mice
harboring inducible Cre alleles, we have noticed variable
recombination efficiency between mice, even within the
same litter and of the same gender. Therefore, assessment
of recombination in every experimental animal is strongly
advised.
The persistence of active TMX increases the likelihood
that a gene locus will undergo successful recombination.
In vivo estimates of TMX half-life is 7 to 11 days [11,12],
therefore, after a 24 h chase or TMX administration
during repair, as performed by Van Maltzahn et al. and
Gunther et al., residual TMX and hence Cre activity
could act on proliferating satellite cells and their down-
stream Pax7 expressing progeny, thus increasing the
likelihood of recombination in escaper cells. This may
explain, in part, why chasing TMX for 1 day instead
of 5 days prior to injury led to a regenerative decline.
In support of the escaper cell hypothesis, proliferative
compensation of satellite cells was prevented after mice
received TMX in their chow during the regeneration
process [8].
The stability of the targeted protein also needs to be
considered when designing a TMX strategy. If protein
turnover is longer than the length of chase period, many
cells will have residual protein at sufficient levels to pre-
serve normal function. Using the Lepper et al. allele and
chasing TMX for months instead of weeks, Gunther
et al. observed a requirement for Pax7 in satellite cell
maintenance and function during repair.
In addition, Gunther et al. examined a different indu-
cible Pax7CreER and Pax7 loxP allele in which Pax7 pro-
tein was more rapidly degraded. A shorter TMX chase
was required to deplete the satellite cell pool and lose
muscle regenerative capacity. Therefore, retention of
Pax7 biological activity altered the kinetics of stemcell diminution. Based on the sum of the data, it is
appropriate to conclude that Pax7 is critical for normal
adult satellite cell function and in its absence skeletal
muscle repair is severely compromised.
While it is becoming clear that high levels of recombin-
ation should not be assumed and strategies to maximize
recombination are desired, caution is also advised. It was
recently demonstrated that TMX promoted apoptosis in
the intestine and biased the contribution of one stem cell
subset over another without impacting tissue morphology
[13]. In the same vein, long-term TMX delivered to mice in
their chow, while increasing recombination efficiency may
have unintentional consequences that influence satellite cell
contributions. Neither Gunther et al. nor Maltzahn et al.
reported detrimental effects of long-term TMX on muscle
regeneration, however its effects on the satellite cell popu-
lation and muscle repair warrants further scrutiny. There-
fore, it is imperative that non-specific effects of TMX
administration and Cre lox recombination that could in-
directly alter cell function are considered and minimized.
On one hand, long-term administration of TMX leads
to greater deletion efficiency but at the same time masks
whether the cellular phenotype is borne from quiescent
cells specifically and/or their Pax7+ progeny. This issue
is particularly relevant if downstream progenitors have
different levels of Pax7 and are biased towards differen-
tiation or self-renewal, as reported [14]. In such a sce-
nario, cells expressing low levels of Pax7 are less likely
recombined and retain wild type function. In addition, it
has become apparent that muscle resident non-satellite
cells participate in muscle repair, of which some cell
types may transiently activate the Pax7 promoter [15-17].
If facultative cells are identified in adult muscle that
express and require Pax7 for muscle contribution, admi-
nistration of TMX immediately before or during repair
will induce recombination in these cells. In contrast,
administering TMX prior to injury and with adequate
chase, would avoid recombination of these transient Pax7
expressers, presumably retaining their normal function
and contribution to muscle tissue repair (see Figure 1).
Therefore, prolonged TMX administration will increase
the likelihood of targeting transient cell populations.
Technologies that allow inducible and reversible gene
deletion strategies such as doxycycline inducible reverse
tetracycline-controlled transactivator system (rtTA) will
allow examination of the state specific role of Pax7 in
satellite cells as they progress along their lineage or other
Pax7 transiently expressed populations as they contribute
to muscle repair.
Due to the caveats of TMX stability, its long-term
administration for effective gene recombination and the
dynamic cell populations within a regenerating muscle,
it would be useful to determine how long TMX can re-
tain recombining activity of satellite cells in vivo. To this
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that are chased for varying lengths of time and subse-
quently injected with satellite cells harboring Pax7C-
reER-loxP ROSA26 reporter alleles into pre-injured
muscle. The presence of reporter expression in the re-
generated muscle would provide an estimate of TMX re-
combining half life. These results would help in the design
of experiments that maximize recombination efficiency in
satellite cells prior to injury, or targeting transit-amplifying
cells (TAC) cells and facultative cells during injury
(see Figure 1).
As the chapter on Pax7? s requirement for adult satellite
cell function comes to a close, what is next for Pax7 and
the satellite cell? The phenotypic differences between the
work of Lepper et al. and that of Van Malzhen et al. and
Gunther et al. can be distilled to the presence or absence
of ? escaper ? cells. Which begs the question: are Pax7+ es-
caper cells a unique population or a stochastic anomaly?
Escape from recombination can arise from many factors,
some technical, such as suboptimal TMX, or biological
variances, including chromatin compaction and gene
methylation or promoter activity. I would argue it unlikely
that TMX dosage played a role. Comparisons between
the different administration strategies employed by Lepper
et al., Van Maltzen et al., and Gunther et al. strongly sug-
gest that cell cycle state (quiescence versus proliferating)
may impose resistance to recombination. It is important
to keep in mind that Lepper et al. observed substantial
recombination of the ROSA26 locus in both neonatal and
adult muscle, however, only in neonatal muscle, which
comprises mainly cycling Pax7+ cells, did a phenotype
manifest.Table 1 Strategies for effective gene recombination in adult s
TMX delivery Recovery period
TMX injection at 3 mg/day for
5 consecutive daysa
Allow >15 days of TMX chase prior to
muscle injury to target quiescent SCs
and minimize lingering TMX activity
Five daily injections prior to injury
followed by continuous TMX
feeding delivered in chow
(1 mg TMX per day)




Cons: Escaper cell contribution
No recovery period
Pros: Maximize targeting of both
stable and transient cell populations
Minimize escaper cell contribution
Cons: Lose cell type and state
resolution
aRecommendation based on 30-gram adult mouse.
bDue to variable recombination efficiency between mice, assessment of recombination
fluorescent reporters as a surrogate to assess recombination of a gene of interest.
cIn the presence of escaper cells, gene/protein levels of the targeted allele will incre
recombination results in a gain-of-function mutant or acts redundantly, then gene/
escaper cells, the gene/protein of interest will not be detectable.A characteristic morphological feature of quiescent stem
cells is their tightly packed heterochromatic state. Is it
possible that escaper cells have more compact chromatin,
which is relieved during the cell cycle? Gunther et al.
highlighted an unappreciated role for Pax7 in maintenance
of the heterochromatic state; after Pax7 deletion, satellite
cells took on a euchromatic morphology, which preceded
their numeric and functional loss. It will be important
to resolve whether subsets of satellite cells have more
densely-packed chromatin and whether deregulation of
chromatin architecture via Pax7-dependent and independ-
ent mechanisms lead to changes in satellite cell function.
Gene methylation is a significant roadblock for Cre me-
diated recombination [18]. Therefore, inaccessible loci will
more likely avoid recombination, leading to the retention
of normal gene function. To circumvent this limitation,
due to its open configuration, the ROSA26 locus is often
targeted to insert Cre mediated reporters. While this is a
reliable approach for lineage tracing studies, it should be
used cautiously as a proxy for gene deletion. Methylation
status of a target gene at the time of TMX administration
will impact the accuracy with which the ubiquitous re-
porter reflects deletion of a specific gene. Therefore, direct
measurement of recombination of the targeted gene locus
or protein within the cell of interest is critical. In Table 1 I
have outlined TMX strategies for optimal gene recombin-
ation, measuring recombination efficiency and testing
escaper cell contribution.
Conclusions
In closing, the studies from Gunther et al. and Van
Maltzen et al. wrap up the debate about the importanceatellite cells and their progeny during muscle repair
Gene deletion analysis Escaper cell analysis
Isolate purified SCs by FACS,
or from single fibers from
each experimental animalb
Measure gene or protein levels
over timec
Measurement of protein
by western blot or
immunohistochemistry
In vitro: Measure gene/protein
immediately after isolation and after
approximately 10 days in culture
Quantify DNA directly at the
gene locus using site-specific
primers flanking the loxP sites
In vivo: Measure gene/protein
from SCs isolated from uninjured
and regenerated muscle (>30 days
after injury)
in every mouse is strongly advised. In addition, I caution the use of R26R-based
ase over time if the recombined gene has a loss-of-function phenotype. If
protein levels will decrease or not change, respectively. In the absence of
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anisms that preserve satellite cell homeostasis in the
absence of injury, the role of Pax7 as a modifier of
chromatin architecture, and the requirement of Pax7
in muscle resident facultative cells are not yet solved.
In addition, while we critically try to minimize, or at
least control for, the limitations of inducible Cre lox
technology, it is also worth considering the possibility
that such limitations, if understood, may be exploited
to help define cellular and molecular heterogeneity
within the satellite cell compartment.
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